Skip to main content

Table 2 Descriptive statistics of clinical outcomes by extent of kidney disease

From: Post-surgical outcomes of patients with chronic kidney disease and end stage renal disease undergoing radical prostatectomy: 10-year results from the US National Inpatient Sample

Clinical outcomes

All patients (N = 136,790)

Non-CKD (n = 134,751)

CKD (n = 1,766)

ESRD (n = 273)

p-value1

Length of stay

2.11 ± 0.02

2.09 ± 0.02

3.16 ± 0.11

4.33 ± 0.41

<.001

Postoperative complication

12434 (9.1)

12011 (8.9)

364 (20.6)

59 (21.6)

<.001

 In-hospital mortality

55 (0.04)

51 (0.04)

2 (0.1)

2 (0.7)

<.001

 Cardiovascular complications

943 (0.7)

889 (0.7)

46 (2.7)

8 (3)

<.001

 Bleeding complications

7974 (5.8)

7708 (5.7)

230 (13)

36 (13.2)

<.001

 Pulmonary complications

1251 (0.9)

1158 (0.9)

75 (4.2)

18 (6.5)

<.001

 Infection/sepsis

303 (0.2)

273 (0.2)

22 (1.2)

8 (3)

<.001

 DVT / Pulmonary embolism

204 (0.2)

189 (0.1)

13 (0.8)

2 (0.7)

<.001

 Wound complications

694 (0.5)

662 (0.5)

24 (1.3)

8 (2.9)

<.001

 Device complications

28 (0.02)

20 (0.02)

1 (0.1)

7 (2.5)

<.001

 Other complications

4689 (0.08)

4575 (3.4)

102 (5.8)

12 (4.4)

<.001

 Postoperative AKI and urinary complicationsa

1999 (1.5)

1704 (1.3)

295 (16.4)

<.001

  1. Continuous variables are presented as mean ± standard error
  2. Categorical variables are presented as unweighted counts (weighted percentage)
  3. CKD chronic kidney disease, ESRD end stage renal disease, DVT deep vein thrombosis, AKI acute kidney injury
  4. 1Chi-square p-values are given for categorical variables, and Wald F-test p-values for continuous variables
  5. aThe ESRD group was not included in the analysis of postoperative AKI and urinary complications